All In MedTech

Device Trial Radar · NCT03804060

REperfusion With Cooling in CerebraL Acute IscheMia II

A Multicenter, Prospective, Randomized-controlled Trial to Assess the Safety and Feasibility of Cooling as an Adjunctive Therapy to Thrombectomy and Reperfusion in Patients With Acute Cerebral Ischemia and Stroke

Last checked: Nov 20, 2026Latest source record: May 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

90

Actual

Start

May 23, 2019

Primary completion

May 1, 2024

Study completion May 1, 2024

Sponsor

Lead sponsor
ZOLL Circulation, Inc., USANot on our public-company list
Sponsor type
Industry
First posted
Jan 15, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to determine the feasibility and safety of achieving rapid hypothermia with the Proteus Intravascular Temperature Management (IVTM) system for patients experiencing acute ischemic stroke due to a large vessel occlusion.

Conditions

  • Ischemic Stroke

Interventions

  • Thermogard XP3Device

    Cooling with the ZOLL® Circulation catheter and the ZOLL® Intravascular Temperature Management system to initiate and maintain hypothermia for 6 hours as an adjunct to endovascular Recanalization.

  • Recanalization onlyProcedure

    Standard of Care for recanalization

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Test Arm patients achieving target temperatureTime frame: 1 hour after thrombectomy
  2. Mean door-to-Recanalization timeTime frame: perioperative
  3. Rate of hemorrhagic conversion in each arm within 36 hours of RecanalizationTime frame: 36 hours

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • WellStar Kennestone Regional Medical Center

    Marietta, Georgia

  • The Queen's Medical Center

    Honolulu, Hawaii

  • University of Chicago Medical Center

    Chicago, Illinois

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.